Results 121 to 130 of about 5,576 (168)

Self and parasite-derived peptides selected upon DERAA-bearing HLA-DRB1 alleles activate CD4+ T cells from Chagas cardiomyopathy patients and are associated with ventricular dysfunction. [PDF]

Front Immunol
Souza-Silva TG, Neves EGA, Teixeira-Carvalho A, Figueiredo AB, Morais KLP, Apostólico J, Rodrigues H, Kalil J, Juliano MA, Juliano L, Araújo SS, Pantaleao AN, Mutarelli A, Nunes MCP, Gollob KJ, Dutra WO.   +15 more
europepmc   +1 more source

Unraveling the role of miRNAs as biomarkers in Chagas cardiomyopathy: Insights into molecular pathophysiology. [PDF]

PLoS Negl Trop Dis
Ribeiro HG, Galdino OA, de Souza KSC, Rosa Neta AP, Lin-Wang HT, Cunha-Neto E, Rezende AA, Silbiger VN.   +7 more
europepmc   +1 more source

Adipocyte-released adipomes in Chagas cardiomyopathy: Impact on cardiac metabolic and immune regulation. [PDF]

iScience
Thangavel H, Dhanyalayam D, Kim M, Lizardo K, Sidrat T, Lopez JG, Wang X, Bansal S, Nagajyothi JF.   +8 more
europepmc   +1 more source

Amiodarone or Implantable Cardioverter-Defibrillator in Chagas Cardiomyopathy: The CHAGASICS Randomized Clinical Trial.

JAMA Cardiol
Martinelli-Filho M, Marin-Neto JA, Scanavacca MI, de Paola AAV, Medeiros PTJ, Owen R, Pocock SJ, de Siqueira SF, CHAGASICS investigators.   +8 more
europepmc   +1 more source

Factors influencing the use of direct oral anticoagulants among patients with chronic chagas cardiomyopathy. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Gómez-Ochoa SA, Rojas LZ, Alarcón Meléndez LJ, Quintero Santana MA, Becerra-Motta LP, Serrano-García AY, Echeverría LE.   +6 more
europepmc   +1 more source

Assessment of Plasma Exovesicles and Prothrombotic Biomarkers Suggest Prethrombotic Conditions in Chagas Cardiomyopathy in Colombia. [PDF]

Clin Appl Thromb Hemost
Jaimes-Dueñez JE, Álvarez K, Eduardo-Echeverria L, Cáceres-Rivera DI, Rojas LZ, Gómez-Ochoa SA, Daniela-Muñoz L, Cantillo-Reines M, Tique-Oviedo M, Eresbey-Granada Y, Triana-Chávez Biol O.   +10 more
europepmc   +1 more source

Chagas cardiomyopathy in Boston, Massachusetts: Identifying disease and improving management after community and hospital-based screening. [PDF]

PLoS Negl Trop Dis
Reifler KA, Wheelock A, Hall SM, Salazar A, Hassan S, Bostrom JA, Barnett ED, Carrion M, Hochberg NS, Hamer DH, Gopal DM, Bourque D.   +11 more
europepmc   +1 more source

Correlation of blood-based immune molecules with cardiac gene expression profiles reveals insights into Chagas cardiomyopathy pathogenesis. [PDF]

Front Immunol
Souza-Silva TG, Neves EGA, Koh C, Teixeira-Carvalho A, Araújo SS, Nunes MDCP, Gomes JAS, Gollob KJ, Dutra WO.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chagas Disease Cardiomyopathy

Dimensions of Critical Care Nursing, 2023
Abstract Chagas disease is a prominent neglected tropical disease endemic to many countries in Latin America. Cardiomyopathy is the most serious manifestation due to the severity and complications of heart failure. As a result of expanded immigration and globalization, there is an increased number of patients with Chagas cardiomyopathy who are being ...
Ariana, Jimenez, Elizabeth J, Winokur
openaire   +2 more sources

Chagas Disease: Chronic Chagas Cardiomyopathy

Current Problems in Cardiology, 2021
Chagas disease (CD) is a tropical vector-borne infection caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), also known as American Trypanosomiasis. It is considered endemic in all South and Central America and in this past decades its becoming a burden particularly in the United States and Europe due to human migration. The vast majority of
Natalia Giraldo Echavarría, Luis E. Echeverría, Merrill Stewart, Catalina Gallego, Clara Saldarriaga   +4 more
openaire   +2 more sources